Search | IOVS | ARVO Journals

Showing 1 – 20 of 48

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2021

The HORNBILL study: A Phase I/IIa trial examining the safety of BI-X in patients with diabetic macular ischemia and diabetic retinopathy treated with pan-retinal photocoagulation

Quan Dong Nguyen; Harsha Sen; Raj K Maturi; Louis-Josef Bour; Sobha Sivaprasad; Elizabeth Pearce; Victor Chong

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1074.

Retina January 2021

Diabetic Macular Ischemia: Influence of Optical Coherence Tomography Angiography Parameters on Changes in Functional Outcomes Over One Year

PDF

Andrew S. H. Tsai; Janice Marie Jordan-Yu; Alfred T. L. Gan; Kelvin Y. C. Teo; Gavin S. W. Tan; Shu Yen Lee; Victor Chong; Chui Ming Gemmy Cheung

Invest. Ophthalmol. Vis. Sci.. 2021; 62(1):9. https://doi.org/10.1167/iovs.62.1.9

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2020

Incidence and prevalence of moderate to severe non-proliferative diabetic retinopathy within an English Screening Programme

Emily Fletcher; Clareece R Kerby; Irene Mary Stratton; Sobha Sivaprasad; Clare Bailey; Elvira Massó-González; Sonia Maruti; Michael Ehrlich; Victor Chong; Peter Henry Scanlon

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3830.

Clinical Trials March 2020

Bradykinin 1 Receptor Antagonist BI1026706 Does Not Reduce Central Retinal Thickness in Center-Involved Diabetic Macular Edema

PDF

Gabriele E. Lang; Ramin Tadayoni; Wenbo Tang; Claudia Barth; Cornelia Weiss-Haljiti; Victor Chong; on behalf of the BI 1026706 Study Group
TAGS: antagonists, bradykinin, diabetic macular edema, placebos, surrogate endpoints, safety, kininogenase, kinins
Trans. Vis. Sci. Tech.. 2020; 9(4):25. https://doi.org/10.1167/tvst.9.4.25

Articles December 2019

Microperimetry in Age-Related Macular Degeneration: An Evidence-Base for Pattern Deviation Probability Analysis in Microperimetry

PDF

Nicola K. Cassels; John M. Wild; Tom H. Margrain; Chris Blyth; Victor Chong; Jennifer H. Acton
TAGS: age-related macular degeneration, color, evidence-based practice
Trans. Vis. Sci. Tech.. 2019; 8(6):48. https://doi.org/10.1167/tvst.8.6.48

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2019

Effectiveness of subthreshold laser therapy for non-center-involving diabetic macular edema

Ernest Junwei Lim; Matthew Stahl; Samia Fatum; Colm Andrews; Victor Chong; Christine A Kiire

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2597.

ARVO Annual Meeting Abstract July 2019

Aflibercept can reduce the severity of deep hemorrhages and IRMA but not venous beading

Liz Pearce; Victor Chong; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6546.

Visual Neuroscience May 2019

Impact of Diabetic Retinopathy on Sleep, Mood, and Quality of Life

PDF

Rupal Morjaria; Iona Alexander; Robert M. J. Purbrick; Rukhsana Safa; Ngaihang Victor Chong; Katharina Wulff; Russell G. Foster; Susan M. Downes; for the SOMNUS Study Group
TAGS: diabetic retinopathy, mood, quality of life, sleep, sleep quality
Invest. Ophthalmol. Vis. Sci.. 2019; 60(6):2304-2310. https://doi.org/10.1167/iovs.18-26108

Retina December 2018

Optical Coherence Tomography Angiography in Familial Exudative Vitreoretinopathy: Clinical Features and Phenotype-Genotype Correlation

PDF

Chonglin Chen; Chengxi Liu; Zhirong Wang; Limei Sun; Xiujuan Zhao; Songshan Li; Xiaoling Luo; Aiyuan Zhang; Victor Chong; Lin Lu; Xiaoyan Ding
TAGS: familial exudative vitreoretinopathies, phenotype, angiogram, genotype, signs and symptoms, optical coherence tomography
Invest. Ophthalmol. Vis. Sci.. 2018; 59(15):5726-5734. https://doi.org/10.1167/iovs.18-25377

ARVO Annual Meeting Abstract September 2016

Association of fluid recurrence with visual maintenance following the loading phase in anti-VEGF therapy for neovascular AMD

Sebastian M Waldstein; Victor Chong; Michael Larsen; James Warburton; Andreas Weichselberger; Jonathan Wright; Ursula Schmidt-Erfurth

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):533.

ARVO Annual Meeting Abstract September 2016

Achievement of ≥20/40 vision with ranibizumab in patients with diabetic macular edema: a post-hoc analysis of the RESTORE study

Victor Chong; Jonathan Alsop; Philippe Margaron; Paul Mitchell

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2079.

ARVO Annual Meeting Abstract September 2016

The predictive features of optical coherent topography in anatomical response to ranibizumab in patients with diabetic macular edema

Angela Ding; Samia Fatum; Victor Chong

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2090.

ARVO Annual Meeting Abstract September 2016

Segmented SD-OCT imaging and microperimetry outcomes in age-related macular degeneration

Nicola Cassels; John Wild; Tom Margrain; Liz Pearce; Chris Blyth; Sobha Sivaprasad; Victor Chong; Jennifer Acton

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2656.

ARVO Annual Meeting Abstract September 2016

Vision-related quality of life and clinical measures of visual function in age-related macular degeneration

Elizabeth Pearce; Nicola Cassels; Sobha Sivaprasad; Tom Margrain; Chris Blyth; John Wild; Victor Chong; Jennifer Acton

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5601.

ARVO Annual Meeting Abstract June 2015

Factors affecting the conversion rate of the fellow eye of patients with neovascular age-related macular degeneration over 5 years

Elizabeth Pearce; Sobha Sivaprasad; Victor Chong

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5153.

ARVO Annual Meeting Abstract June 2015

Genotype-phenotype correlation of diabetic macular edema in type 2 diabetes

Christine A Kiire; Suzanne Broadgate; Stephanie Halford; Victor Chong

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1461.

ARVO Annual Meeting Abstract June 2015

Diabetic Macular Edema response to Intravitreal Ranibizumab

Farihah S Tariq; Samia Fatum; Victor Chong

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1758.

ARVO Annual Meeting Abstract April 2014

Subfoveal choroidal thickness is not correlated with retinal sensitivity but with age in the fellow eye of patients with neovascular age-related macular degeneration

Elizabeth Pearce; Elizabeth Yang; Joshua Harvey; Matthew Richardson; Sobha Sivaprasad; Victor Chong

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1095.

ARVO Annual Meeting Abstract April 2014

Classification of Diabetic Macular Edema Based on the Morphology in Optical Coherent Topography

Andrew Want; Rebecca Rewbury; Rachel Varughese; Victor Chong

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3423.

ARVO Annual Meeting Abstract April 2014

To investigate the impact of diabetic retinopathy of varying severity on sleep.

Rupal Morjaria; Iona Alexander; Obaid Kousha; Rukhsana Safa; Robert Malcolm John Purbrick; Victor Chong; Katharina Wulff; Russell G Foster; Susan M Downes; Foster Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3495.

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

The HORNBILL study: A Phase I/IIa trial examining the safety of BI-X in patients with diabetic macular ischemia and diabetic retinopathy treated with pan-retinal photocoagulation

Diabetic Macular Ischemia: Influence of Optical Coherence Tomography Angiography Parameters on Changes in Functional Outcomes Over One Year

Incidence and prevalence of moderate to severe non-proliferative diabetic retinopathy within an English Screening Programme

Bradykinin 1 Receptor Antagonist BI1026706 Does Not Reduce Central Retinal Thickness in Center-Involved Diabetic Macular Edema

Microperimetry in Age-Related Macular Degeneration: An Evidence-Base for Pattern Deviation Probability Analysis in Microperimetry

Effectiveness of subthreshold laser therapy for non-center-involving diabetic macular edema

Aflibercept can reduce the severity of deep hemorrhages and IRMA but not venous beading

Impact of Diabetic Retinopathy on Sleep, Mood, and Quality of Life

Optical Coherence Tomography Angiography in Familial Exudative Vitreoretinopathy: Clinical Features and Phenotype-Genotype Correlation

Association of fluid recurrence with visual maintenance following the loading phase in anti-VEGF therapy for neovascular AMD

Achievement of ≥20/40 vision with ranibizumab in patients with diabetic macular edema: a post-hoc analysis of the RESTORE study

The predictive features of optical coherent topography in anatomical response to ranibizumab in patients with diabetic macular edema

Segmented SD-OCT imaging and microperimetry outcomes in age-related macular degeneration

Vision-related quality of life and clinical measures of visual function in age-related macular degeneration

Factors affecting the conversion rate of the fellow eye of patients with neovascular age-related macular degeneration over 5 years

Genotype-phenotype correlation of diabetic macular edema in type 2 diabetes

Diabetic Macular Edema response to Intravitreal Ranibizumab

Subfoveal choroidal thickness is not correlated with retinal sensitivity but with age in the fellow eye of patients with neovascular age-related macular degeneration

Classification of Diabetic Macular Edema Based on the Morphology in Optical Coherent Topography

To investigate the impact of diabetic retinopathy of varying severity on sleep.

To View More...

You must be signed into an individual account to use this feature.